Sign In
Buy PACB
$1.45
-0.180 (-11.04%)
At Close: Jun 05, 2026
PacBio to Report Second Quarter 2024 Financial Results on August 7, 2024
04:03pm, Monday, 15'th Jul 2024
MENLO PARK, Calif., July 15, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its second quarter 2024 financial results on Wedn
Reasons to Retain PacBio (PACB) Stock in Your Portfolio Now
01:01pm, Tuesday, 02'nd Jul 2024
PacBio's (PACB) strong product demand and continued focus on R&D raise optimism about the stock.
PacBio (PACB) and Form Bio to Boost AAV Industry Development
05:11am, Tuesday, 02'nd Jul 2024
PacBio (PACB) and Form Bio collaborate to form an expert AAV Working Group to introduce essential tools for AAV development and research professionals.
Pacific Biosciences of California (PACB) Advances While Market Declines: Some Information for Investors
07:20pm, Friday, 28'th Jun 2024
In the most recent trading session, Pacific Biosciences of California (PACB) closed at $1.37, indicating a +0.74% shift from the previous trading day.
Jefferies Says Buy These 3 Stocks for More Than Double-Digit Returns
10:12am, Thursday, 13'th Jun 2024
We are almost halfway through 2024, and the stock market is putting on a masterclass performance. The S&P 500 is up 12% year-to-date after rising 23% last year.
PacBio and International Research Consortium CoLoRS Announce Release of First-Ever HiFi Long-Read Variant Database
09:05am, Monday, 10'th Jun 2024
Consortium Delivers Publicly Available Datasets that Enrich Detection of Rare and Novel Genetic Variants for Advances in Human Disease Research MENLO PARK, Calif. , June 10, 2024 /PRNewswire/ -- PacB
Reasons to Retain PacBio (PACB) Stock in Your Portfolio
02:01pm, Wednesday, 29'th May 2024
PacBio's (PACB) strong product demand and continued focus on R&D raise optimism about the stock.
Pacific Biosciences of California, Inc. (PACB) Is a Trending Stock: Facts to Know Before Betting on It
10:02am, Thursday, 23'rd May 2024
Zacks.com users have recently been watching Pacific Biosciences (PACB) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Consortium Selects Leading Genomics Companies to Support Pediatric Mendelian Genomics Research Center Program ALISO VIEJO, Calif. and MENLO PARK, Calif.
PacBio (PACB) Q1 Earnings In Line, Adjusted Gross Margin Up
12:21pm, Friday, 10'th May 2024
PacBio (PACB) reports growth in Product revenues in the first quarter of 2024. However, Instruments revenues decline year over year due to lower shipment of Revio units.
Pacific Biosciences of California, Inc. (PACB) Q1 2024 Earnings Call Transcript
09:49pm, Thursday, 09'th May 2024
Pacific Biosciences of California, Inc. (NASDAQ:PACB ) Q1 2024 Earnings Conference Call May 9, 2024 5:00 PM ET Company Participants Todd Friedman - Senior Director of Investor Relations Christian Henr
Pacific Biosciences (PACB) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
07:31pm, Thursday, 09'th May 2024
While the top- and bottom-line numbers for Pacific Biosciences (PACB) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metri
Pacific Biosciences of California (PACB) Reports Q1 Loss, Tops Revenue Estimates
07:11pm, Thursday, 09'th May 2024
Pacific Biosciences of California (PACB) came out with a quarterly loss of $0.26 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.31 per share a year ago.
PacBio Announces First Quarter 2024 Financial Results
04:05pm, Thursday, 09'th May 2024
MENLO PARK, Calif. , May 9, 2024 /PRNewswire/ -- PacBio (NASDAQ: PACB) today announced financial results for the quarter ended March 31, 2024.
Soft Instrument Orders Likely to Hurt PacBio's (PACB) Q1 Earnings
01:16pm, Tuesday, 07'th May 2024
Despite strength in Revio and Onso platforms, an increasing number of customers delaying instrument purchases is likely to have dampened PacBio's (PACB) top line in the first quarter.
